Drug manufacturing giant GSK is subverting its pledge to lower the price of its brand-name inhaler products, a key Democratic senator alleged. In a letter to CEO Emma Walmsley made public Thursday, Sen. Maggie Hassan (D-N.H.) said the company appears to be circumventing its public commitment to cap the price of many of its brand-name…